These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24903568)

  • 1. Cytomegalovirus antiviral resistance: characterization of results from clinical specimens.
    Kleiboeker S; Nutt J; Schindel B; Dannehl J; Hester J
    Transpl Infect Dis; 2014 Aug; 16(4):561-7. PubMed ID: 24903568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.
    Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K
    J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD
    Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
    Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
    J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.
    Choi SH; Hwang JY; Park KS; Kim Y; Lee SH; Yoo KH; Kang ES; Ahn JH; Sung KW; Koo HH; Kim YJ
    Transpl Infect Dis; 2014 Dec; 16(6):919-29. PubMed ID: 25405808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
    Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
    J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.
    Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H
    Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of human cytomegalovirus UL97 and UL54 mutations for antiviral resistance in clinical specimens.
    Daikoku T; Saito K; Aihara T; Ikeda M; Takahashi Y; Hosoi H; Nishida T; Takemoto M; Shiraki K
    Microbiol Immunol; 2013 May; 57(5):396-9. PubMed ID: 23668613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis.
    James SH; Prichard MN
    Infect Disord Drug Targets; 2011 Oct; 11(5):504-13. PubMed ID: 21827431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.
    Castor J; Cook L; Corey L; Jerome KR
    J Clin Microbiol; 2007 Aug; 45(8):2681-3. PubMed ID: 17537934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing for cytomegalovirus antiviral resistance genotyping in a clinical virology laboratory.
    Chorlton SD; Ritchie G; Lawson T; McLachlan E; Romney MG; Matic N; Lowe CF
    Antiviral Res; 2021 Aug; 192():105123. PubMed ID: 34174249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing.
    Guermouche H; Burrel S; Mercier-Darty M; Kofman T; Rogier O; Pawlotsky JM; Boutolleau D; Rodriguez C
    Antiviral Res; 2020 Jan; 173():104647. PubMed ID: 31706899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deletion at CMV UL54 codon 524 without co-existing resistance-associated mutation at UL97 confers resistance to ganciclovir: A case report.
    Green CB; O'Riordan A; Griffiths P; Haque T
    J Clin Virol; 2016 Jul; 80():24-6. PubMed ID: 27131599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan.
    Yang SL; Lin TW; Lin HC; Wang HY; Chang PY; Wang PN; Yang S; Lu JJ
    J Microbiol Immunol Infect; 2021 Oct; 54(5):971-978. PubMed ID: 33632621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus.
    Posthuma CC; van der Beek MT; van der Blij-de Brouwer CS; van der Heiden PL; Marijt EW; Spaan WJ; Claas EC; Nederstigt C; Vossen AC; Snijder EJ; Kroes AC
    J Clin Virol; 2011 May; 51(1):25-30. PubMed ID: 21388868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutations in the
    Demin MV; Tikhomirov DS; Biderman BV; Drokov MY; Sudarikov AB; Tupoleva TA; Filatov FP
    Vopr Virusol; 2022 Mar; 67(1):37-47. PubMed ID: 35293187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir.
    Boutolleau D; Burrel S; Agut H
    Antiviral Res; 2011 Jul; 91(1):32-5. PubMed ID: 21570426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection and quantitation of ganciclovir resistance in cytomegalovirus quasispecies.
    Ruiz-Carrascoso G; Romero-Gómez MP; Plaza D; Mingorance J
    J Med Virol; 2013 Jul; 85(7):1250-7. PubMed ID: 23592041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
    Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.